Back to Search Start Over

Treatment and Prophylaxis of Post-pericardiotomy Syndrome in Cardiac Surgery Patients: a Systematic Review.

Authors :
Giacinto O
Minati A
Lusini M
Cardetta F
Saltarocchi S
D'Abramo M
Miraldi F
Chello M
Source :
Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2023 Aug; Vol. 37 (4), pp. 771-779. Date of Electronic Publication: 2021 Sep 21.
Publication Year :
2023

Abstract

Purpose: Post-pericardiotomy syndrome (PPS) is a common complication of cardiac surgery. This systematic review aimed to investigate the efficacy of colchicine, indomethacin, and dexamethasone in the treatment and prophylaxis of PPS.<br />Methods: Literature research was carried out using PubMed. Studies investigating ≥ 10 patients with clinically PPS treated with colchicine, dexamethasone, and indomethacin and compared with placebo were included. Animal or in vitro experiments, studies on < 10 patients, case reports, congress reports, and review articles were excluded. Cochrane risk-of-bias tool for randomized trials (RoB2) was used for the quality assessment of studies.<br />Results: Seven studies were included. Among studies with postoperative colchicine treatment, two of them demonstrated a significant reduction of PPS. In the single pre-surgery colchicine administration study, a decrease of PPS cases was registered. Indomethacin pre-surgery administration was linked to a reduction of PPS. No significant result emerged with preoperative dexamethasone intake.<br />Conclusion: Better outcomes have been registered when colchicine and indomethacin were administered as primary prophylactic agents in preventing PPS and PE. Further RCT studies are needed to confirm these results.<br /> (© 2021. The Author(s).)

Details

Language :
English
ISSN :
1573-7241
Volume :
37
Issue :
4
Database :
MEDLINE
Journal :
Cardiovascular drugs and therapy
Publication Type :
Academic Journal
Accession number :
34546452
Full Text :
https://doi.org/10.1007/s10557-021-07261-4